Connect with us


Cuba starts clinical trials of 2 new domestic vaccines against COVID-19 – Authority



The Cuban Centre for State Control of Medicines, Equipment and Medical Devices approved the launch of clinical trials of two COVID-19 candidate vaccines developed by the Cuban Centre of Genetic Engineering and Biotechnology (CIGB), official said.

CIGB Director Eulogio Pimentel Vazquez said this on Friday.

“The clinical trials of candidate vaccines Mambisa and Abdala have been approved.

“After a thorough review of the presented dossier that included the evidence of the results of the pharmaceutical development and animal trials,” Dr Pimental wrote on Twitter.

READ ALSO:   Coronavirus: African Union Member States reporting COVID-19 cases as of 11 December 2020, 6 pm EAT

According to the CIGB, the Mambisa vaccine will be injected through the nose to examine the immune response at the mucous level.

The aim of the Abdala vaccine trial is to evaluate its safety in the first phase and its immune response capacity in the second phase.

Apart from Mambisa and Abdala vaccines, Cuba is conducting clinical trials of two other domestic vaccines.

Earlier in August, Cuban Finlay Institute started developing Soberana 01 vaccine, with trials expected to be finished in January 2021.

READ ALSO:   U.S.-China trade negotiators vow to implement phase one deal

At the end of October, the state control authority approved the first phase trials of the Soberana 02 vaccine against the coronavirus disease.

Edited By: Fatima Sule/Ekemini Ladejobi

NNN is a Nigerian online news portal that publishes breaking news in Nigeria, and across the world. Our journalists are honest, fair, accurate, thorough and courageous in gathering, reporting and interpreting news in the best interest of the public, because truth is the cornerstone of journalism and they strive diligently to ascertain the truth in every news report. Contact: editor[at] Disclaimer.